Italian Association Amici di Raoul Follereau (AIFO)

Contact

General

Project Support

Alliances & Links

Resources & Training

ARCHIVES OF LEPROSY MAILING LIST
Archives of recent messages from Leprosy Mailing List (LML) managed by Dr Salvatore Noto.

Over the past few years, LML moderated by Dr Noto has become one of the most important online resource for promoting discussions about leprosy. For joining this mailing list kindly send an email to Dr. Salvatore Noto: salvatore.notoathsanmartino.it  (substitute at with @ in the email address)

Leprosy mailing list – December 2nd, 2005

Ccn:     all.

From:   H Cross, USA.


 

  

 

Dear Dr Noto,

 

Further to the reading on silent neuritis suggested by Jiske Erlings (LML Nov. 18th, 2005) I would also recommend that any study of the subject should include a knowledge of the work as published in the articles below:

 

1.

Smith WC, Anderson AM, Withington SG, van Brakel WH, Croft RP, Nicholls PG et al. Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1). BMJ 2004;328:1459.
 

2.

van Brakel WH, Anderson AM, Withington SG, Croft RP, Nicholls PG, Richardus JH et al. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2). Lepr.Rev. 2003;74:300-10.
 

3.

Saunderson P, Gebre S, Desta K, Byass P, Lockwood DN. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome. Lepr.Rev. 2000;71:285-308.


4.

Saunderson P, Gebre S, Desta K, Byass P. The ALERT MDT Field Evaluation Study (AMFES): a descriptive study of leprosy in Ethiopia. Patients, methods and baseline characteristics. Lepr.Rev. 2000;71:273-84.

 

5.
Croft RP, Nicholls PG, Richardus JH, Smith WC. Incidence rates of acute nerve function impairment in leprosy: a prospective cohort analysis after 24 months (The Bangladesh Acute Nerve Damage Study). Lepr.Rev. 2000;71:18-33.


6.
Croft RP, Richardus JH, Nicholls PG, Smith WC. Nerve function impairment in leprosy: design, methodology, and intake status of a prospective cohort study of 2664 new leprosy cases in Bangladesh (The Bangladesh Acute Nerve Damage Study). Lepr.Rev. 1999;70:140-59.

   

7.
Richardus JH, Finlay KM, Croft RP, Smith WC. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh. Lepr.Rev. 1996;67:297-305.

8. 

 van Brakel WH,. Khawas IB. Nerve function impairment in leprosy: an epidemiological and clinical study--Part 2: Results of steroid treatment. Lepr.Rev. 1996;67:104-18.

 

9.

 van Brakel WH,. Khawas IB. Silent neuropathy in leprosy: an epidemiological description. Lepr.Rev. 1994;65:350-60.

 

10.

 van Brakel WH,.Khawas IB. Nerve damage in leprosy: an epidemiological and clinical study of 396 patients in west Nepal--Part 1. Definitions, methods and frequencies. Lepr.Rev. 1994;65:204-21.

 

11. 

van Brakel WH, Khawas IB, Lucas SB. Reactions in leprosy: an epidemiological study of 386 patients in west Nepal. Lepr.Rev. 1994;65:190-203.

 

12. 

 van Brakel WH, Shute J, Dixon JA, Arzet H. Evaluation of sensibility in leprosy--comparison of various clinical methods. Lepr.Rev. 1994;65:106-21.

 

I would be grateful if you would convey this message to those who may be interested.

 

Regards,

 

Hugh Cross

 

<< BACK TO LML ARCHIVE INDEX

 

AIFO, Via Borselli 4-6, 40135 Bologna, Italy
Tel: +390-51-4393.211 Fax: +390-51-434046 Email: info@aifo.it